These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 23692381)

  • 81. Preclinical safety, toxicology, and biodistribution study of adenoviral gene therapy with sVEGFR-2 and sVEGFR-3 combined with chemotherapy for ovarian cancer.
    Tuppurainen L; Sallinen H; Kokki E; Koponen J; Anttila M; Pulkkinen K; Heikura T; Toivanen P; Hämäläinen K; Kosma VM; Heinonen S; Alitalo K; Ylä-Herttuala S
    Hum Gene Ther Clin Dev; 2013 Mar; 24(1):29-37. PubMed ID: 23692381
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Adenovirus-mediated p53 gene therapy: overview of preclinical studies and potential clinical applications.
    Horowitz J
    Curr Opin Mol Ther; 1999 Aug; 1(4):500-9. PubMed ID: 11713766
    [TBL] [Abstract][Full Text] [Related]  

  • 83. [Promising new drugs in the treatment of ovarian cancer, and of gynecologic tumors, in general].
    Di Leo A
    Tumori; 1999; 85(3 Suppl 1):S27-9. PubMed ID: 10542883
    [No Abstract]   [Full Text] [Related]  

  • 84. qPCR and qRT-PCR analysis: Regulatory points to consider when conducting biodistribution and vector shedding studies.
    Ma H; Bell KN; Loker RN
    Mol Ther Methods Clin Dev; 2021 Mar; 20():152-168. PubMed ID: 33473355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 5.